TY  - GEN 
AU  - González Salvatierra, Sheila
AU  - García Fontana, Cristina
AU  - Andújar Vera, Francisco Luis
AU  - Martínez Heredia, Luis
AU  - Sanabria de la Torre, Raquel
AU  - Ferrer Millán, Maria
AU  - Moratalla Aranda, Enrique
AU  - Muñoz Torres, Manuel Eduardo
AU  - García Fontana, Beatriz
PY  - 2023
UR  - https://hdl.handle.net/10481/86344
AB  - Background

Sclerostin is an inhibitor of the Wnt/b-catenin pathway, which regulates bone formation, and can be expressed in vascular smooth muscle cells (VSMCs). Type 2 diabetes (T2D) is associated with an increased risk of cardiovascular disease...
LA  - eng
PB  - Springer Nature
KW  - Type 2 Diabetes
KW  - Cardiovascular Diseases
KW  - Atherosclerosis
KW  - Sclerostin
KW  - Vascular smooth muscle cells
KW  - Protective role
TI  - Cardioprotective function of sclerostin by reducing calcium deposition, proliferation, and apoptosis in human vascular smooth muscle cells
DO  - 10.1186/s12933-023-02043-8
ER  -